James Schaub
Overview
James Schaub received an average of $907K in total compensation, including $398K in salary, at RVL Pharmaceuticals plc from 2018 to 2022.
2022RVL Pharmaceuticals plcEVP and Chief Operating Officer
2021RVL Pharmaceuticals plcEVP and Chief Operating Officer
2020RVL Pharmaceuticals plcEVP and Chief Operating Officer
2019RVL Pharmaceuticals plcEVP and Chief Operating Officer
2018RVL Pharmaceuticals plcEVP and Chief Operating Officer
Source: SEC filings on April 24, 2023, April 25, 2022, April 26, 2021, and April 20, 2020.
Related executives
We found four more executives who work or worked at RVL Pharmaceuticals plc.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019